RNA Analytical/Quality Videos
-
Assessing The Quality & Maturity Of The Next-Gen Oligo Supply Chain
12/3/2025
As our molecules grow more complicated, so, too, does the supply chain. Here, Advancing RNA Live speakers Khaled Yamout & Camp4’s Satya Kuchimanchi talk through how this growth challenges our understanding of raw material quality and how sponsors can better assess their suppliers.
-
Webinar Teaser: LBA Vs. LC-MS
2/6/2025
Why are so many sponsors shifting from Ligand-Binding Assays (LBA) to Liquid Chromatography-Mass Spectrometry (LC-MS) for large molecule protein analysis?
-
Therapeutic Market Opportunities For mRNA
10/16/2023
In this segment from the Bioprocess Online Live digital event Risk Reduction In mRNA Therapeutic Development, hundreds of audience members tell us what forms of vaccine and therapeutics they’re developing.
-
Establishing Analytical Methods For Emerging mRNA-Based Therapies
6/5/2023
Here, we describe the use of cutting-edge technologies to assess critical quality attributes of both mRNA drug substances and drug products.
-
Improving IVT Processes: Addressing Analytical Limitations & PAT Shortcomings
4/11/2025
Advancing RNA Live panelists identify what is “as good as we can get right now” in terms of understanding our IVT reactions while sharing their ideas on how we can arrive at a future that includes real-time monitoring of our drug substance production processes.
-
Don't Ignore These Functional Areas In Your RNA Therapeutic's Regulatory Story
5/10/2024
Explore two functional areas that Advancing RNA panelists consider most essential to telling an RNA product’s “story” thoroughly to regulators.
-
RNA Interference - From Single Gene Studies To Whole Genome Screens
11/7/2022
Endoribonuclease-prepared siRNAs (esiRNAs) are able to overcome the limitations of RNAi. Learn about esiRNAs, their advantages over standard siRNAs, and ways this technology is utilized in different research fields.
-
Robust And Cost-Effective mRNA Capping
12/8/2025
Master the essential strategies for cost-effective and robust mRNA capping at industrial scale. Learn how to successfully evaluate new materials and optimize your synthesis process for maximum efficiency and yield.
-
Engaging Early In Process Development To Bring mRNA Sequences To Life
Examine why template sequence characteristics are relevant for cGMP manufacturing of high-quality mRNA and consider insights on how to develop a scalable, robust, and economically viable process.
-
Customized mRNA Processing For Improved Therapy Development And Manufacturing
2/13/2025
Optimize mRNA development by learning key strategies for process refinement, critical component identification, and in-process analytics to enhance therapeutic production.